# Elica Health Centers

Health Center, CA
Page: https://astrelis.co/providers/health_center/551093  
This twin: https://astrelis.co/providers/health_center/551093.md  
CMS Certification Number (CCN): 551093  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2025)

- **Total patients (UDS) (FY2024):** 63,348. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2025):** -2.1%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 16. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 14.6%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2025):** $89.2M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2025):** +20.0%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### ELICA HEALTH CTR, CA

Match to this profile: matched by name (method: name and state).

- FY ending 2025-12-31 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-12-GSAFAC-0000429796
- FY ending 2024-12-31 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-12-GSAFAC-0000372115
- FY ending 2023-12-31 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-12-GSAFAC-0000056189

| Line | FY ending 2025-12-31 | FY ending 2024-12-31 | FY ending 2023-12-31 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 41,940,835 [derived, p.5] | 23,134,377 [derived, p.5] | 5,455,247 [derived, p.5] |
| patient receivables, net (Statement of financial position) | 10,981,018 [derived, p.5] | 11,306,985 [derived, p.5] | 13,591,628 [derived, p.5] |
| grants and other receivables (Statement of financial position) | 269,970 [derived, p.5] | 563,319 [derived, p.5] | 589,392 [derived, p.5] |
| other current assets (Statement of financial position) | 748,856 [derived, p.5] | 694,189 [derived, p.5] | 482,064 [derived, p.5] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 53,940,679 [extracted, p.5] | 35,698,870 [extracted, p.5] | 20,118,331 [extracted, p.5] |
| property and equipment, net (Statement of financial position) | 23,456,579 [derived, p.5] | 25,245,391 [derived, p.5] | 27,756,703 [derived, p.5] |
| other long-term assets (Statement of financial position) | 36,838,882 [derived, p.5] | 30,140,290 [derived, p.5] | 36,198,404 [derived, p.5] |
| TOTAL ASSETS (Statement of financial position) | 114,236,140 [extracted, p.5] | 91,084,551 [extracted, p.5] | 84,073,438 [extracted, p.5] |
| payables and accrued expenses (Statement of financial position) | 5,470,722 [derived, p.5] | 5,455,746 [derived, p.5] | 5,677,885 [derived, p.5] |
| deferred revenue (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| current debt and leases (Statement of financial position) | 4,606,045 [derived, p.5] | 7,314,929 [derived, p.5] | 5,463,720 [derived, p.5] |
| other current liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 10,076,767 [extracted, p.5] | 12,770,675 [extracted, p.5] | 11,141,605 [extracted, p.5] |
| long-term debt and leases (Statement of financial position) | 46,760,858 [derived, p.5] | 41,362,923 [derived, p.5] | 43,390,092 [derived, p.5] |
| other long-term liabilities (Statement of financial position) | 1,196,747 [derived, p.5] | 1,990,110 [derived, p.5] | 3,246,573 [derived, p.5] |
| TOTAL LIABILITIES (Statement of financial position) | 58,034,372 [extracted, p.5] | 56,123,708 [extracted, p.5] | 57,778,270 [extracted, p.5] |
| net assets without donor restrictions (Statement of financial position) | 56,201,768 [derived, p.5] | 34,960,843 [derived, p.5] | 26,295,168 [derived, p.5] |
| net assets with donor restrictions (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL NET ASSETS (Statement of financial position) | 56,201,768 [extracted, p.5] | 34,960,843 [extracted, p.5] | 26,295,168 [extracted, p.5] |
| patient service revenue, net (Statement of activities) | 92,169,238 [derived, p.6] | 82,029,352 [derived, p.6] | 63,085,157 [derived, p.6] |
| pharmacy and 340B revenue (Statement of activities) | 9,414,773 [derived, p.6] | 6,634,388 [derived, p.6] | 8,283,808 [derived, p.6] |
| federal grants (Statement of activities) | 5,547,614 [derived, p.6] | 3,640,668 [derived, p.6] | 6,175,588 [derived, p.6] |
| other grants and contracts (Statement of activities) | absent (not printed, or not read) | 5,005,282 [derived, p.6] | 4,305,004 [derived, p.6] |
| contributions (Statement of activities) | absent (not printed, or not read) | 2,626,954 [derived, p.6] | 1,993,789 [derived, p.6] |
| other revenue (Statement of activities) | 2,376,811 [derived, p.6] | 630,545 [derived, p.6] | 1,017,520 [derived, p.6] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 109,508,436 [extracted, p.6] | 100,567,189 [extracted, p.6] | 84,860,866 [extracted, p.6] |
| salaries and benefits (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| supplies and pharmaceuticals (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| purchased and professional services (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| occupancy (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| depreciation and amortization (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| interest (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other expenses (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL EXPENSES (Statement of activities) | 98,537,746 [extracted, p.6] | 91,901,514 [extracted, p.6] | 80,569,539 [extracted, p.6] |
| OPERATING RESULT (Statement of activities) | 10,970,690 [extracted, p.6] | absent (not printed, or not read) | absent (not printed, or not read) |
| non-operating and other changes (Statement of activities) | 10,270,235 [derived, p.6] | absent (not printed, or not read) | absent (not printed, or not read) |
| CHANGE IN NET ASSETS (Statement of activities) | 21,240,925 [extracted, p.6] | 8,665,675 [extracted, p.6] | 4,291,327 [extracted, p.6] |
| net assets, beginning (Statement of activities) | 34,960,843 [extracted, p.6] | 26,295,168 [extracted, p.6] | 22,003,841 [extracted, p.6] |
| net assets, end (Statement of activities) | 56,201,768 [extracted, p.6] | 34,960,843 [extracted, p.6] | 26,295,168 [extracted, p.6] |

| Ratio | FY ending 2025-12-31 | FY ending 2024-12-31 | FY ending 2023-12-31 |
|---|---:|---:|---:|
| Days cash on hand | absent [not computed] | absent [not computed] | absent [not computed] |
| Current ratio | 5.35x [plausible] | 2.80x [plausible] | 1.81x [plausible] |
| Operating margin | 10.0% [plausible] | absent [not computed] | absent [not computed] |
| Total margin | 19.4% [plausible] | 8.6% [plausible] | 5.1% [plausible] |
| Patient revenue share | 84.2% [plausible] | 81.6% [plausible] | 74.3% [plausible] |
| Grant dependency | absent [not computed] | 8.6% [plausible] | 12.4% [plausible] |
| Salaries share | absent [not computed] | absent [not computed] | absent [not computed] |
| Days in patient receivables | 43 days [plausible] | 50 days [plausible] | 79 days [plausible] |
| Debt to net assets | 0.91x [plausible] | 1.39x [plausible] | 1.86x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Probable). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (ELICA HEALTH CTR; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Elica Health Centers", https://astrelis.co/providers/health_center/551093, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.